Development of a brief cognitive screen for mild cognitive impairment and neurocognitive disorder

Aging, Neuropsychology, and Cognition

Volumn 12, Issue 4, 2005, Pages 299-315

  Woodard, John L ^a   Dorsett, Elinor S W ^a   Cooper, James G ^b   Hermann, Bruce P ^b   Sager, Mark A ^b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DRAWING; EVALUATION; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PATIENT CODING; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; RATING SCALE; RECALL; REGISTER; SAMPLE SIZE; SCORING SYSTEM; SCREENING TEST;

EID: 28744435506     PISSN: 13825585     EISSN: None     Source Type: Journal    
DOI: 10.1080/138255890968268     Document Type: Article

References (45)

1. American Psychiatric Association (1995). Diagnostic and Statistical Manual of Mental Disorders, Revised Fourth Edition. Washington, D.C.: American Psychiatric Association.
2. Cahn-Weiner, D. A., Sullivan, E. V., Shear, P. K., Fama, R., Lim, K. O., & Yesavage, J. A., et al. (1999). Brain structural and cognitive correlates of clock drawing performance in Alzheimer's disease. Journal of the International Neuropsychological Society, 5, 502-509.
3. Celsis, P. (2000). Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease? Annals of Medicine, 32, 6-14.
4. Crook, T., Bartus, R. T., Ferris, S. H., Whitehouse, P., Cohen, G. D., & Gershon, S. (1986). Age-Associated Memory Impairment: Proposed diagnostic criteria and measures of clinical change - Report of a National Institute of Mental Health Work Group. Developmental Neuropsychology, 2, 261-276.
5. Ebly, E. M., Hogan, D. B., & Parhad, I. M. (1995). Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. Archives of Neurology, 52, 612-619.
6. Flicker, C., Ferris, S. H., & Reisberg, B. (1991). Mild cognitive impairment in the elderly: Predictors of dementia. Neurology, 41, 1006-1009.
7. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
8. Graham, J. E., Rockwood, K., Beattie, B. L., Eastwood, R., Gauthier, S., & Tuokko, H. et al. (1997). Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet, 349, 1793-1796.
9. Green, R. C., Woodard, J. L., & Green, J. (1995). Validity of the Mattis Dementia Rating Scale for detection of cognitive impairment in the elderly. Journal of Neuropsychiatry Clinical Neuroscience, 7, 357-360.
10. rd ed.). Upper Saddle River, NJ: Prentice Hall.
11. Hanninen, T., Hallikainen, M., Tuomainen, S., Vanhanen, M., & Soininen, H. (2002). Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurologica Scandinavia, 106, 148-154.
12. Hochberg, Y., & Tamhane, A.C. (1987). Multiple comparison procedures. New York: John Wiley.
13. Ivnik, R., Malec, J., Smith, G., Tangalos, E., Petersen, R., & Kokmen, E. et al. (1992). Mayo's older Americans normative studies: Updated AVLT norms for ages 56 to 97. The Clinical Neuropsychologist, 6(Supplement), 83-104.
14. Kraemer, H. C. (1992). Evaluating medical tests. Newbury Park, CA: Sage.
15. Kral, V. (1962). Senescent forgetfulness: benign and malignant. Canadian Medical Association Journal, 86, 257.
16. Kral, V. A. (1966). Memory loss in the aged. Diseases of the Nervous System, 27, 51-54.
17. Lezak, M. D. (1995). Neuropsychological assessment (3rd ed.). New York: Oxford.
18. Lucas, J. A., Ivnik, R. J., Smith, G. E., Bohac, D. L., Tangalos, E. G., & Kokmen, E. et al. (1998). Normative data for the Mattis Dementia Rating Scale. Journal of Clinical and Experimental Neuropsychology, 20, 536-547.
19. Mackinnon, A. (2000). A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement. Computers in Biology and Medicine, 30, 127-134.
20. Mattis, S. (1988). Dementia Rating Scale professional manual. Odessa, Florida: Psychological Assessment Resources, Inc.
21. Monsch, A. U., Bondi, M. W., Salmon, D. P., Butters, N., Thal, L. J., & Hansen, L. A. et al. (1995). Clinical validity of the Mattis Dementia Rating Scale in detection of dementia of the Alzheimer type. Archives of Neurology, 52, 899-904.
22. Morris, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., & Fillenbaum, G. et al. (1989). The consortium to establish a registry for Alzheimer's disease (CERAD). Part 1. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology, 39, 1159-1165.
23. Mundt, J. C., Freed, D. M., & Greist, J. H. (2000). Lay person-based screening for early detection of Alzheimer's disease: development and validation of an instrument. Journal of Gerontology B: Psychological Science and Social Science, 55, P163-170.
24. Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., & Rabins, P. V. et al. (2001). Current concepts in mild cognitive impairment. Archives of Neurology, 58, 1985-1992.
25. Petersen, R. C., Smith, G. E., Ivnik, R. J., Tangalos, E. G., Schaid, D. J., & Thibodeau, S. N. et al. (1995). Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA, 273, 1274-1278.
26. Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56, 303-308.
27. Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L., & DeKosky, S. T. (2001). Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 56, 1133-1142.
28. Pryse-Phillips, W., Sternberg, S., Rochon, P., Naglie, G., Strong, H., & Feightner, J. (2001). The use of medications for cognitive enhancement. Canadian Journal of Neurolological Science, 28(Suppl 1), S108-114.
29. Rey, A. (1964). L'examen clinique en psychologie. Paris: Presses Universitaire de France.
30. Ritchie, K., Artero, S., & Touchon, J. (2001). Classification criteria for mild cognitive impairment: a population-based validation study. Neurology, 56, 37-42.
31. Rubin, E. H., Morris, J. C., Grant, E. A., & Vendegna, T. (1989). Very mild senile dementia of the Alzheimer type. I. Clinical assessment. Archives of Neurology, 46, 379-382.
32. Salmon, D. P., Kwo-on-Yuen, P. F., Heindel, W. C., Butters, N., & Thal, L. J. (1989). Differentiation of Alzheimer's disease and Huntington's disease with the dementia rating scale. Archives of Neurology, 46, 1204-1208.
33. Shay, K. A., Duke, L. W., Conboy, T., Harrell, L. E., Callaway, R., & Folks, D. G. (1991). The clinical validity of the Mattis Dementia Rating Scale in staging Alzheimer's dementia. Journal of Geriatric Psychiatry and Neurology, 4, 18-25.
34. Sheikh, J. L., & Yesavage, J. A. (1986). Geriatric Depression Scale (GDS): Recent evidence and development for a shorter version. Clinical Gerontologist, 5, 165-172.
35. Smith, G. E., Ivnik, R. J., Malec, J. F., Kokmen, E., Tangalos, E., & Petersen, R. C. (1994). Psychometric properties of the Mattis Dementia Rating Scale. Assessment, 1, 123-131.
36. Sternberg, S. A., Wolfson, C., & Baumgarten, M. (2000). Undetected dementia in community-dwelling older people: the Canadian Study of Health and Aging. Journal of the American Geriatric Society, 48, 1430-1434.
37. Tierney, M. C., Szalai, J. P., Snow, W. G., Fisher, R. H., Nores, A., & Nadon, G. et al. (1996). Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study. Neurology, 46, 661-665.
38. Tröster, A. I., Moe, K. E., Vitiello, M. V., & Prinz, P. N. (1994). Predicting long-term outcome in individuals at risk for Alzheimer's disease with the Dementia Rating Scale. Journal of Neuropsychiatry and Clinical Neuroscience, 6, 54-57.
39. Tuokko, H., & Frerichs, R. J. (2000). Cognitive impairment with no dementia (CIND): longitudinal studies, the findings, and the issues. The Clinical Neuropsychologist, 14, 504-525.
40. Vangel, S. J., & Lichtenberg, P. A. (1995). Mattis Dementia Rating Scale: Clincal utility and relationship with demographic variables. The Clinical Neuropsychologist, 9, 209-213.
41. Welsh, K., Butters, N., Hughes, J., Mohs, R., & Heyman, A. (1991). Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Archives of Neurology, 48, 278-281.
42. Welsh, K. A., Butters, N., Hughes, J. P., Mohs, R. C., & Heyman, A. (1992). Detection and staging of dementia in Alzheimer's disease: Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Archives of Neurology, 49, 429-576.
43. Welsh, K. A., Fillenbaum, G., Wilkinson, W., Heyman, A., Mohs, R. C., & Stern, Y. et al. (1995). Neuropsychological test performance in African-American and white patients with Alzheimer's disease. Neurology, 45, 2207-2211.
44. Wilkinson, G. S. (1993). Wide Range Achievement Test-3 (WRAT-3) administration manual, Wilmington, DE: Wide Range.
45. Woodard, J. L., Salthouse, T. A., Godsall, R. E., & Green, R. C. (1996). Confirmatory factor analysis of the Mattis Dementia Rating Scale in patients with Alzheimer's Disease. Psychological Assessment, 8, 85-91.